,,ii #aaf? ,,congress #a/ ,session ,s4 #cjac ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,decemb] #aj1 #bjai,mr4 ,toomey 7= himself & ,mr4 ,crapo7 introduc$ ! foll[+ bill2 :i* 0 read twice & ref]r$ to ! ,committee on ,f9ance ,a ,,bill ,to am5d title ,,xviii ( ! ,social ,security ,act to all[ = ! (f]+ ( additional prescription drug plans "u ,m$ic>e "p ,d4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,enc\rag+ ,innovative ,b5efit ,design to ,l[] ,co/s = ,s5iors ,act4 #b4 ,all[+ ! (f]+ ( additional prescription drug plans "u ,m$ic>e "p ,d 7a7 ,resc9d+ & issuance ( new guidance ,n lat] ?an "o ye> aft] ! date ( ! enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices 79 ?is section ref]r$ to z ! ,secret>y7 %all-- 7#a7 resc9d sections ( any sub-regulatory guidance t limit ! numb] ( prescription drug plans 9 ea* ,,pdp region t may be (f]$ by a ,,pdp sponsor "u "p ,d ( title ,,xviii ( ! ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aja et seq472 & 7#b7 issue new guidance specify+ t a ,,pdp sponsor may (f] up to #d 7or a great] numb] if det]m9$ appropriate by ! ,secret>y7 prescription drug plans 9 ea* ,,pdp region1 except 9 case :]e ! ,,pdp sponsor may (f] up to #b additional plans 9 a ,,pdp region pursuant to section #ahfj;,d-#aa7;d77#d7 ( ! ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aaa7;d77#d771 z add$ by subsection 7b74 7b7 ,(f]+ ( additional plans ,section #ahfj;,d-#aa7;d7 ( ! ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aaa7;d77 is am5d$ by add+ at ! end ! foll[+ new p>agraph3 7#d7 ,(f]+ ( additional plans 7,a7 ,9 g5]al ,= plan ye> #bjbb & ea* subsequ5t plan ye>1 a ,,pdp sponsor may (f] up to #b additional prescription drug plans 9 a ,,pdp region 79 addition to any limit e/abli%$ by ! ,secret>y "u ?is "p7 provid$ t ! ,,pdp sponsor complies ) subp>agraph 7,b7 ) respect to at lea/ "o su* prescription drug plan4 7,b7 ,requirem5ts ,9 ord] to be eligible to (f] up to #b additional plans 9 a ,,pdp region pursuant to subp>agraph 7,a71 a ,,pdp sponsor mu/ ensure t1 ) respect to at lea/ "o su* prescription drug plan1 ! sponsor or any entity t provides ph>macy b5efits managem5t s]vices "u a contract ) any su* sponsor or plan does n receive direct or indirect remun]ation1 z def9$ 9 section #dbc4cjh ( title #db1 ,code ( ,f$]al ,regulations 7or any successor regulation71 unless at lea/ #aj p]c5t ( ! aggregate r$uctions 9 price or o!r remun]ation receiv$ by ! ,,pdp sponsor or entity f drug manufactur]s ) respect to ! plan & plan ye>-- 7i7 are reflect$ at ! po9t-(-sale to ! enrollee2 or 7ii7 are us$ to r$uce total b5efici>y co/-%>+ e/imat$ by ! ,,pdp sponsor = prescription drug cov]age "u ! plan 9 ! annual bid submitt$ by ! ,,pdp sponsor "u section #ahfj;,d-#aa7;b74 7,c7 ,def9ition ( r$uctions 9 price ,= purposes ( subp>agraph 7,b71 ! t]m r$uctions 9 price ref]s only to collectible am\nts1 z det]m9$ by ! ,secret>y1 :i* excludes am\nts :i* aft] adjudication & reconciliation ) ph>macies & manufactur]s are duplicate 9 nature1 contr>y to o!r contractual clauses1 or o!rwise ineligible 7su* z due to b5efici>y dis5rollm5t or coord9ation ( b5efits74 4 7c7 ,rule ( con/ruction ,no?+ 9 ! provisions (1 or am5dm5ts made by1 ?is section %all be con/ru$ z limit+ ! ability ( ! ,secret>y to increase any limit o!rwise applicable on ! numb] ( prescription drug plans t a ,,pdp sponsor may (f]1 at ! discretion ( ! ,,pdp sponsor1 9 a ,,pdp region "u "p ,d ( title ,,xviii ( ! ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#aja et seq474